275 related articles for article (PubMed ID: 38683372)
1. Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles.
Mastronikolis NS; Delides A; Kyrodimos E; Piperigkou Z; Spyropoulou D; Giotakis E; Tsiambas E; Karamanos NK
Mol Biol Rep; 2024 Apr; 51(1):597. PubMed ID: 38683372
[TBL] [Abstract][Full Text] [Related]
2. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
Jin Y; Qin X
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
[TBL] [Abstract][Full Text] [Related]
3. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
BMC Med; 2015 May; 13():108. PubMed ID: 25956054
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of LAMTOR5 Predicts Poor Prognosis and Is Associated with Lymph Node Metastasis of Head and Neck Squamous Cell Carcinoma.
Yang QC; Wu CC; Cao LY; Xiao Y; Li H; Liu B; Sun ZJ
Int J Med Sci; 2019; 16(6):783-792. PubMed ID: 31337951
[TBL] [Abstract][Full Text] [Related]
6. Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy.
Sepiashvili L; Hui A; Ignatchenko V; Shi W; Su S; Xu W; Huang SH; O'Sullivan B; Waldron J; Irish JC; Perez-Ordonez B; Liu FF; Kislinger T
Mol Cell Proteomics; 2012 Nov; 11(11):1404-15. PubMed ID: 22918226
[TBL] [Abstract][Full Text] [Related]
7.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
8. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
[TBL] [Abstract][Full Text] [Related]
9. Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma.
Yang P; Huang G; Li Y; Yu L; Yin Z; Li Q
Sci Rep; 2024 Apr; 14(1):9824. PubMed ID: 38684755
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
11. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer-derived copy number alterations signatures are prognostic in chemoradiotherapy-treated head and neck squamous cell carcinoma.
Essers PBM; van der Heijden M; Vossen D; de Roest RH; Leemans CR; Brakenhoff RH; van den Brekel MWM; Bartelink H; Verheij M; Vens C
Int J Cancer; 2020 Sep; 147(6):1732-1739. PubMed ID: 32167160
[TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression in lymph node metastases of head and neck cancer and cancer of unknown primary patients.
Kühn JP; Bochen F; Körner S; Schick B; Wagner M; Smola S; Berkó-Göttel B; Morris LGT; Wang J; Bozzato A; Linxweiler M
Int J Biol Markers; 2022 Sep; 37(3):280-288. PubMed ID: 35880270
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma.
Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y
Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
18. Global Proteomics-based Identification and Validation of Thymosin Beta-4 X-Linked as a Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
Chi LH; Chang WM; Chang YC; Chan YC; Tai CC; Leung KW; Chen CL; Wu AT; Lai TC; Li YJ; Hsiao M
Sci Rep; 2017 Aug; 7(1):9031. PubMed ID: 28831179
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of head and neck squamous cell carcinoma recurrences and distant metastases : Highlights of the 2018 ASCO meeting].
Bußmann L; Münscher A; Busch CJ
HNO; 2018 Dec; 66(12):907-912. PubMed ID: 30377743
[TBL] [Abstract][Full Text] [Related]
20. Circulating Tumour Cell Expression of Immune Markers as Prognostic and Therapeutic Biomarkers in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Payne K; Pugh M; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]